EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Discovery of azaindole/indole-fused pyrimidine tetracyclic scaffolds as novel potent CDK7 inhibitors

Fan Pu, Axiao Tao, Pengxiang Qiu, Weishan Deng, Zijian Chen, Zheng Cao, Yunjiao He, Peng George Wang, Yan Zhang, Chengqing Ning, Xuechen Li, Jing Xu

Journal of Enzyme Inhibition and Medicinal Chemistry · 31.12.2026 · 41 (1)

DOI: 10.1080/14756366.2026.2659998 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Enzyme Inhibition and Medicinal Chemistry, online erschienen am 28.05.2026. Verfasst von Fan Pu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Shenzhen Grubbs Institute and Guangdong Provincial Key Laboratory of Catalysis and Shenzhen Key Laboratory of Small Molec…. Hauptthemen laut MEDLINE: Pyrimidines, Antineoplastic Agents, Protein Kinase Inhibitors, Cyclin-Dependent Kinases. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Science Foundation of China, Shenzhen Key Laboratory of Small Molecule Drug Discovery and Synthesis, Guangdong Provincial Key Laboratory of Catalysis.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyrimidinesAntineoplastic AgentsProtein Kinase InhibitorsCyclin-Dependent KinasesIndolesDrug DiscoveryAza CompoundsHumansCyclin-Dependent Kinase-Activating KinaseStructure-Activity RelationshipCell ProliferationMolecular StructureAnimalsDrug Screening Assays, AntitumorDose-Response Relationship, DrugMiceNeoplasms, Experimental

Stichwörter der Autor:innen

CDK7CDK7 inhibitorsConformational restrictionring closuretetracyclic scaffold

Substanzen

Cyclin-Dependent Kinase-Activating KinasePyrimidinesAntineoplastic AgentsProtein Kinase InhibitorsCyclin-Dependent KinasesIndolesCDK7 protein, humanindolepyrimidineAza Compounds

Autor:innen und Institutionen

  • Department of Chemistry and Shenzhen Grubbs Institute and Guangdong Provincial Key Laboratory of Catalysis and Shenzhen Key Laboratory of Small Molecule Drug Discovery and Synthesis and Guangming Advanced Research Insti…
  • Department of Chemistry, The University of Hong Kong, Hong Kong, People's Republic of China.
  • School of Medicine, Southern University of Science and Technology, Shenzhen, People's Republic of China.
  • SUSTech Academy for Advanced Interdisciplinary Studies, Shenzhen, People's Republic of China.

Förderung

  • National Science Foundation of China
  • Shenzhen Key Laboratory of Small Molecule Drug Discovery and Synthesis
  • Guangdong Provincial Key Laboratory of Catalysis
  • Guangdong Innovative Program
  • the Key Supported Project of SUSTech Guangming Advanced Research Institute

Zitieren

APA

Pu, F., Tao, A., Qiu, P., Deng, W., Chen, Z., Cao, Z., He, Y., Wang, P. G., Zhang, Y., Ning, C., Li, X., & Xu, J. (2026). Discovery of azaindole/indole-fused pyrimidine tetracyclic scaffolds as novel potent CDK7 inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry, 41(1). https://doi.org/10.1080/14756366.2026.2659998

Vancouver

Pu F, Tao A, Qiu P, Deng W, Chen Z, Cao Z, et al. Discovery of azaindole/indole-fused pyrimidine tetracyclic scaffolds as novel potent CDK7 inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry. 2026;41(1). doi:10.1080/14756366.2026.2659998

BibTeX
@article{Pu2026,
  author = {Pu, Fan and Tao, Axiao and Qiu, Pengxiang and Deng, Weishan and Chen, Zijian and Cao, Zheng and He, Yunjiao and Wang, Peng George and Zhang, Yan and Ning, Chengqing and Li, Xuechen and Xu, Jing},
  title = {Discovery of azaindole/indole-fused pyrimidine tetracyclic scaffolds as novel potent CDK7 inhibitors},
  journal = {Journal of Enzyme Inhibition and Medicinal Chemistry},
  year = {2026},
  volume = {41},
  number = {1},
  doi = {10.1080/14756366.2026.2659998}
}
Kostenlos starten →